Skip Navigation

Jefferies says Regeneron's drug Dupixent could drive shares 15% higher

Published Fri, Mar 24 20235:59 AM EDTUpdated Fri, Mar 24 202310:40 AM EDT

Samantha Subin @samantha_subin

NEXT PRO TALK

3 Days Remaining

Wed, May 29 2024 - 7:00am

CNBC Pro Talks: Beyond Nvidia: Outperforming fund manager to reveal the top AI stocks to buy

More In Analyst Calls

A way to play the global nuclear power renaissance from Morgan Stanley

A way to play the global nuclear power renaissance from Morgan Stanley

Spencer Kimball

This power management stock that has doubled over the past year could win big from AI-fueled energy demands

This power management stock that has doubled over the past year could win big from AI-fueled energy demands

Morgan Stanley says these stocks show 'no sign of slowing down' into the summer

Morgan Stanley says these stocks show 'no sign of slowing down' into the summer